Solutions significantly reduce oxygen ingress for drugs in COC syringes.

Blauvelt, NY – Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, will debut barrier function labels that protect against oxygen ingress for drugs contained in COC syringes at Pharmapack Paris, January 24-25, 2024. At its Booth #D78, Schreiner MediPharm also will showcase several other recent product developments.

Prefilled polymer COC syringes have become attractive alternatives to glass syringes. Compared to glass, they offer advantages such as break resistance, lower weight, greater design flexibility, and less protein absorption. However, COC syringes have reduced oxygen and gas barrier properties, which poses challenges particularly with oxygen-sensitive biologics and biosimilars frequently used for treating cancer and autoimmune diseases.

Thanks to their special material selection and design, Schreiner MediPharm’s new labels are equipped with a barrier function that significantly reduces oxygen diffusion in COC syringes. Two variants are available: a Gas-Protect-Label covering the syringe barrel as much as possible; and a Syringe-Closure-Wrap with an additional barrier function that wraps around the syringe barrel and cap like a second skin, and is sealed at the upper end. Due to its integrated first-opening indication, Syringe-Closure-Wrap also provides reliable tamper evidence.

The barrier properties of both label variants have been extensively tested on SCHOTT TOPPAC® 1 ml long COC syringes, and have shown the ability to significantly reduce oxygen ingress. Schreiner MediPharm develops the labels with gas barrier function tailored specifically to individual products and their active pharmaceutical ingredients (APIs). The labels enable pharmaceutical manufacturers to easily implement an oxygen barrier without adjustments to primary packaging or complex processes.

“Thanks to our functional labels with a barrier function, sensitive APIs in COC syringes can be reliably protected against gas diffusion without requiring major capital expenditures. Our solution is a cost-efficient and flexible response to the challenges of the pharmaceutical industry,” says Stefan Wiedemann, Senior Director Strategic Marketing and Business Development at Schreiner MediPharm.